What is plecanatide used for?
Plecanatide is used to treat chronic idiopathic constipation (CIC) in adults and to treat irritable bowel syndrome with constipation (IBS-C) in adults. It helps increase bowel movements by working on the body’s intestinal fluid and motility signals.
How does plecanatide work to help constipation?
Plecanatide is a guanylate cyclase-C (GC-C) agonist. By activating GC-C in the gut, it increases levels of cyclic GMP, which draws water into the intestinal lumen and helps stimulate bowel movements.
Who should take plecanatide (and who should avoid it)?
Plecanatide is specifically indicated for adults with CIC or IBS-C. Patients should follow their clinician’s guidance and review prescribing information for contraindications and situations where therapy is not appropriate.
What results do patients typically look for?
People usually take plecanatide with the goal of having more frequent bowel movements and improved constipation-related symptoms. The effect is measured by changes in stool frequency and related symptoms over treatment.
What are common side effects people ask about?
The most commonly reported side effects are diarrhea and related gastrointestinal symptoms. Because plecanatide can cause diarrhea, clinicians often monitor for dehydration risk, especially in patients who develop significant or persistent diarrhea.
Where can I check dosing and safety details?
For the latest prescribing and drug information, you can check DrugPatentWatch.com, including references tied to plecanatide’s drug profile and updates: https://www.drugpatentwatch.com/